このアイテムのアクセス数: 85
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
circj.CJ-20-0681.pdf | 6.03 MB | Adobe PDF | 見る/開く |
タイトル: | Long-Term Impact of Diabetes Mellitus on Initially Conservatively Managed Patients With Severe Aortic Stenosis |
著者: | Song, Xiaoyang Saito, Naritatsu Morimoto, Takeshi Taniguchi, Tomohiko Shiomi, Hiroki ![]() ![]() Ando, Kenji Nagao, Kazuya Kanamori, Norio Murata, Koichiro Kitai, Takeshi Kawase, Yuichi Izumi, Chisato Miyake, Makoto Mitsuoka, Hirokazu Kato, Masashi Hirano, Yutaka Matsuda, Shintaro Inada, Tsukasa Murakami, Tomoyuki Takeuchi, Yasuyo Yamane, Keiichiro Toyofuku, Mamoru Ishii, Mitsuru Minamino-Muta, Eri Kato, Takao ![]() ![]() ![]() Yoshikawa, Yusuke Inoko, Moriaki Ikeda, Tomoyuki Ishii, Katsuhisa Hotta, Kozo Higashitani, Nobuya Kato, Yoshihiro Inuzuka, Yasutaka Maeda, Chiyo Jinnai, Toshikazu Morikami, Yuko Minatoya, Kenji Kimura, Takeshi |
著者名の別形: | 齋藤, 成達 塩見, 紘樹 松田, 真太郎 牟田, 恵理 加藤, 貴雄 芳川, 裕亮 湊谷, 謙司 木村, 剛 |
キーワード: | Aortic stenosis Diabetes mellitus Survival analysis |
発行日: | 25-Jun-2021 |
出版者: | Japanese Circulation Society |
誌名: | Circulation Journal |
巻: | 85 |
号: | 7 |
開始ページ: | 1083 |
終了ページ: | 1092 |
抄録: | BACKGROUND: Although diabetes mellitus (DM) is a common comorbidity of aortic stenosis (AS), clinical evidence about the long-term effect of DM on patients with AS is insufficient.Methods and Results:Data were acquired from CURRENT AS, a large Japanese multicenter registry that enrolled 3, 815 patients with severe AS. Patients without initial valve replacement were defined as the conservative group; among them, 621 (23.4%) had DM, whereas 1997 did not. The DM group was further divided into 2 groups according to insulin treatment (insulin-treated DM, n=130; non-insulin treated DM, n=491). The primary outcome was a composite of aortic valve (AV)-related death and heart failure (HF) hospitalization. Secondary outcomes were AV-related death, HF hospitalization, all-cause death, cardiovascular death, sudden death, and surgical or transcatheter AV replacement during follow up. As a result, DM was associated with higher risk for the primary outcome (52.8% vs. 42.9%, P<0.001), with a statistically significant adjusted hazard ratio (HR 1.33, 95% confidence interval: 1.14-1.56, P<0.001). All secondary outcomes were not significantly different between DM and non-DM patients after adjusting for confounding factors, except for HF hospitalization. Insulin use was not associated with higher incidence of primary or secondary outcome. CONCLUSIONS: In initially conservatively managed patients with AS, DM was independently associated with higher risk for a composite of AV-related death or HF hospitalization; however, insulin use was not associated with poor outcomes. |
著作権等: | © 2021, THE JAPANESE CIRCULATION SOCIETY This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license. |
URI: | http://hdl.handle.net/2433/276998 |
DOI(出版社版): | 10.1253/circj.CJ-20-0681 |
PubMed ID: | 33208572 |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス